Fisher & Paykel Healthcare has provided its guidance for the first half of the 2026 financial year, projecting revenue of approximately $1.075 billion and net profit after tax of about $200 million.
This represents around 13% growth in reported operating revenue and 31% growth in reported net profit compared to the same period in the 2025 financial year.
The company's outlook for the full 2026 financial year remains unchanged, with operating revenue expected to be in the range of $2.15b to $2.25b and net profit after tax estimated at $390m to $440m.
The company also announced the retirement of director Pip Greenwood, effective September 1, 2025.
See more
